Relationship between bladder cancer and polymorphisms of OX40 (rs17568) and OX40L (rs1234313) genes in a Turkish population

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):1–8. doi: 10.3322/caac.21492.
   Web of Science ®Google Scholar
• Kaufman DS, Shipley WU, Feldman AS. Bladder cancer. Lancet. 2009;374(9685):239–249. doi: 10.1016/S0140-6736(09)60491-8.
   PubMed Web of Science ®Google Scholar
• Junttila TT, Laato M, Vahlberg T, et al. Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reserve transcription-PCR analysis in estimation of ErbB receptor status from cancer patients. Clin Cancer Res. 2003;9(14):5346–5357.
   PubMed Web of Science ®Google Scholar
• Wigner P, Grębowski R, Bijak M, et al. The interplay between oxidative stress, inflammation and angiogenesis in bladder cancer development. Int J Mol Sci. 2021;22(9):4483. doi: 10.3390/ijms22094483.
   PubMed Web of Science ®Google Scholar
• Deng J, Zhao S, Zhang X, et al. OX40 (CD134) and OX40 ligand, important immune checkpoints in cancer. OncoTargets Ther. 2019;12:7347–7353. doi: 10.2147/OTT.S214211.
   PubMed Web of Science ®Google Scholar
• Figueroa JD, Ye Y, Siddiq A, et al. Genome-wide association study identifies multiple loci associated with bladder cancer risk. Hum Mol Genet. 2014;23(5):1387–1398. doi: 10.1093/hmg/ddt519.
   PubMed Web of Science ®Google Scholar
• Lenis AT, Lec PM, Chamie K, et al. Bladder cancer: a review. JAMA. 2020;324(19):1980–1991. doi: 10.1001/jama.2020.17598.
   PubMed Web of Science ®Google Scholar
• Lubrano di Ricco M, Ronin E, Collares D, et al. Tumour necrosis factor receptor family co-stimulation increases regulatory T-cell activation and function via NF-κB. Eur J Immunol. 2020;50(7):972–985. doi: 10.1002/eji.201948393.
   PubMed Web of Science ®Google Scholar
• Redmond WL, Ruby CE, Weinberg AD. The role of OX40-mediated co-stimulation in T cell activation and survival. Crit Rev Immunol. 2009;29(3):187–201. doi: 10.1615/critrevimmunol.v29.i3.10.
   PubMed Web of Science ®Google Scholar
• Vakil Monfared R, Mashayekhi F. OX40L gene polymorphism and breast cancer in Iranian population. Exp Oncol. 2018;40(2):132–135. doi: 10.31768/2312-8852.2018.40(2):132-135.
   PubMedGoogle Scholar
• Balaji S, Terrero D, Tiwari AK, et al. Alternative approaches to overcome chemoresistance to apoptosis in cancer. Adv Protein Chem Struct Biol. 2021;126:91–122.
   PubMed Web of Science ®Google Scholar
• Lamm DL. Long-term results of intravesical therapy for superficial bladder cancer. Urol Clin North Am. 1992;19(3):573–580. doi: 10.1016/S0094-0143(21)00424-9.
   PubMed Web of Science ®Google Scholar
• Narayan VM, Dinney CPN. Intravesical gene therapy. Urol Clin North Am. 2020;47(1):93–101. doi: 10.1016/j.ucl.2019.09.011.
   PubMed Web of Science ®Google Scholar
• Ozturk T, Kahraman OT, Toptaş B, et al. The effect of CYP1A1 and GSTM1 gene polymorphisms in bladder cancer development in a Turkish population. In Vivo. 2011;25(4):663–668.
   PubMed Web of Science ®Google Scholar
• Avirmed S, Khuanbai Y, Sanjaajamts A, et al. Modifying effect of smoking on GSTM1 and NAT2 in relation to the risk of bladder cancer in Mongolian population: a case-control study. Asian Pac J Cancer Prev. 2021;22(8):2479–2485. doi: 10.31557/APJCP.2021.22.8.2479.
   PubMedGoogle Scholar
• Crispen PL, Kusmartsev S. Mechanisms of immune evasion in bladder cancer. Cancer Immunol Immunother. 2020;69(1):3–14. doi: 10.1007/s00262-019-02443-4.
   PubMed Web of Science ®Google Scholar
• Zaini J, Andarini S, Tahara M, et al. OX40 ligand expressed by DCs costimulates NKT and CD4+ Th cell antitumour immunity in mice. J Clin Invest. 2007;117(11):3330–3338. doi: 10.1172/JCI32693.
   PubMed Web of Science ®Google Scholar
• Gupta V, Kumar S, Pratap A, et al. Association of ITGAM, TNFSF4, TNFAIP3 and STAT4 gene polymorphisms with risk of systemic lupus erythematosus in a North Indian population. Lupus. 2018;27(12):1973–1979. doi: 10.1177/0961203318786432.
   PubMed Web of Science ®Google Scholar
• Wang X, Luan Y, Zhang C. A meta-analysis on correlations of OX40L variants with atherosclerotic disorders. J Cell Biochem. 2019;120(6):9624–9630. doi: 10.1002/jcb.28240.
   PubMed Web of Science ®Google Scholar
• Maalhagh M, Shojaei M, Erfanian S, et al. Lack of association between rs17568 polymorphism in ox40 gene and myocardial infarction, Southern of Iran. Glob J Health Sci. 2015;8(6):41–46. doi: 10.5539/gjhs.v8n6p41.
   PubMedGoogle Scholar
• Jiang Y, Cheng L, Li X, et al. Associations between TNFSF4, TNFSF8 and TNFSF15 and Behçet’s disease but not VKH syndrome in Han Chinese. Oncotarget. 2017;8(62):105037–105046. doi: 10.18632/oncotarget.22064.
   PubMedGoogle Scholar
• Faghih Z, Abtahi S, Khademi B, et al. Association of OX40 gene polymorphisms (rs17568G/a and rs229811A/C) with head and neck squamous cell carcinoma. Mol Biol Rep. 2019;46(3):2609–2616. doi: 10.1007/s11033-019-04602-3.
   PubMed Web of Science ®Google Scholar
• Faghih Z, Taherifard E, Daneshmand A, et al. OX40 genetic variations in patients with breast cancer: a case-control study. Br J Biomed Sci. 2021;78(1):44–46. doi: 10.1080/09674845.2020.1776587.
   PubMed Web of Science ®Google Scholar
• Ria M, Eriksson P, Boquist S, et al. Human genetic evidence that OX40 is implicated in myocardial infarction. Biochem Biophys Res Commun. 2006;339(3):1001–1006. doi: 10.1016/j.bbrc.2005.11.092.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhang L, Huang H, et al. Association of OX40 and OX40L gene polymorphisms with acute coronary syndrome in a Han Chinese population. DNA Cell Biol. 2011;30(8):597–602. doi: 10.1089/dna.2010.1201.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Liu X, Du Y, et al. Rs1234313 and rs45454293 are risk factors of cerebral arterial thrombosis, large artery atherosclerosis, and carotid plaque in the Han Chinese population: a case-control study. BMC Neurol. 2019;19(1):31–40. doi: 10.1186/s12883-019-1259-9.
   PubMedGoogle Scholar
• Huang Q, Yang OI, Tan XL, et al. Absence of association between atherosclerotic cerebral infarction and TNFSF4/TNFRSF4 single nucleotide polymorphisms rs1234313, rs1234314 and rs17568 in a Chinese population. J Int Med Res. 2014;42(2):436–443. doi: 10.1177/0300060514521154.
   PubMed Web of Science ®Google Scholar
• Cheng G, Wang H, Chen M, et al. Lack of evidence to support the association of polymorphisms within the TNFSF4 gene and coronary heart disease in a Chinese Han population. Exp Ther Med. 2011;2(2):275–280. doi: 10.3892/etm.2010.188.
   PubMed Web of Science ®Google Scholar
• Weiguang Y, Dalin X, Lidan X, et al. Association of OX40L polymorphisms with sporadic breast cancer in northeast Chinese Han population. PLoS One. 2012;7(8):e41277. doi: 10.1371/journal.pone.0041277.
   PubMed Web of Science ®Google Scholar
• Ensembl.org [Internet]. Variation of rs17568 in human population. [cited 2022 Dec 1]. Available from: http://www.ensembl.org/Homo_sapiens/Variation/Population?db=core;r=1:1211542-1212542;v=rs17568;vdb=variation;vf=18479.
   Google Scholar
• Ensembl.org [Internet]. Variation of rs1234313 in human population. [cited 2022 Dec 1]. Available from: http://www.ensembl.org/Homo_sapiens/Variation/Population?db=core;r=1:173196608-173197608;v=rs1234313;vdb=variation;vf=798897.
   Google Scholar